Effect of combination therapy with a methionine-mitomycin C conjugate and a methionine-deficient diet on tumor growth

In Vivo

Volumn 12, Issue 3, 1998, Pages 351-355

  Yoshida, Shogo ^a,b   Yamana, Hideaki ^a   Tanaka, Toshiaki ^a   Ishibashi, Nobuya ^a   Toh, Uhi ^a   Ishii, Hiroshi ^a   Shirouzu, Yuichirou ^a   Shirouzu, Kazuo ^a  

^a Kurume University   (Japan)

^b KURUME UNIVERSITY   (Japan)

Author keywords

Chemotherapy; Esophageal cancer; Methionine; Tumor growth

Indexed keywords

METHIONINE; MITOMYCIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; DRUG CONJUGATION; ESOPHAGUS CANCER; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; TUMOR GROWTH; TUMOR VOLUME;

EID: 0031854094     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Ghose T and Blair AH: Antibody-Jinked cytotoxic agents in the treatment of cancer current status and future prospects. J Natl Cancer Inst 61: 657-676, 1978.
2. Toh U, Yamana H, Fuijita H, Toh Y, Fujii T, Kubo K et al: A monoclonal antibody KIS-1 recognizing a new membrane antigen on human squamous-cell carcinoma. Int J Cancer 66: 600-606, 1996.
3. Higaki K: Experimental studies on immuno-targeting therapy of antiesophageal antibody and vindesine conjugate. J Kurume Med Associ 57: 812-821, 1994. (in Japanese with English abstract).
4. Hoffman RM: Methionine dependence in cancer cells; a review. In Vitro 18: 421-428, 1990.
5. Kreis W: Tumor therapy by deprivation of L-methionine: rationale and results. Cancer Treat Report 63: 1069-1072, 1979.
6. Halpern BC, Clark BR, Hardy DN, Halpern RM, and Smith RA: The effect of methionine replacement by homocystine on survival of malignant and normal mammalian cells in culture. Proc Natl Acad Sci USA 71: 1133-1136, 1974.
7. Guo H, Herrera H, Groce A, and Hoffman RM: Expression of the biochemical defect of methionine dependence in fresh patients tumors in primary histoculture. Cancer Res 55: 2479-2483, 1993.
8. Goseki N, Endo M, Onodera T, and Kousaki G: Anti-tumor effect of L-methionine deprived total parenteral nutrition with 5-fluorouracil administration on Yoshida sarcoma-bearing rats. Ann Surg 214: 83-88, 1991.
9. Guo H, Lishko VK, Herrera H, Grouce A, Kubota T, and Hoffman RM: Therapeutic tumor-specific cell cycle block induced by methionine starvation in vivo. Cancer Res 53: 5676-5679, 1993.
10. Yoshida S, Yamasaki K, Kaibara A, Takagi K, Noake T, Ishibashi N, and Kakegawa T: Effect of methionine-deprived total parenteral nutrition on tumor protein turnover in rats. Cancer 76: 1275-1282, 1995.
11. Toh U, Yoshida S, Yamana H, Ishibashi N, Noake T, and Kakegawa T: Effect of methionine deprivation on methionine incorporation into the tumor protein in tumor bearing nude mice. Proceedings of XVI International Cancer Congress, Rao R.S. (ed), pp. 7-10, 1994.
12. Rebek J, and Fehler D: An improved method for the study of reaction intermediates. The mechanism of peptide synthesis mediated by carbodiimide. J Am Chem Soc 95: 4052-4053, 1973.
13. Keane TJ, Harwood AR, Elhakim T et al: Radical radiation therapy with 5 fluorouracil infusion and mitomycin C for oesophageal squamous carcinoma. Radiation Oncol 4: 205-210, 1985.
14. Kurihara M, Taguchi T and Kosaki G: A randomized control study of methionine-deprived amino acid solution (AO-90) in advanced gastric cancer patients. Proceedings of 13th Annual Meeting of the American Society of Clinical Oncology, May 14-17, Dallas, Texas, (1994)(abstract).